Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
98.75 HKD | -3.85% | -3.14% | -10.35% |
05-21 | Glenmark Pharma Arm to Market Two Beigene Cancer Drugs in India | MT |
05-14 | BeiGene Highlights New Hematology Portfolio and Pipeline Data at EHA2024 | CI |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
114B | ||||||
107B | ||||||
22.22B | - | |||||
21.28B | - | |||||
18.8B |